Class of antiretroviral drugs and the risk of myocardial infarction.
Friis-Møller N; Reiss P; Sabin CA; Weber R; Monforte Ad; El-Sadr W; Thiébaut R; De Wit S; Kirk O; Fontas E; Law MG; Phillips A; Lundgren JD; The New England Journal Of Medicine, 2007, vol. 356, issue 17, p 1723, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation